Chathuri Daluwatte, Head of AI Diagnostics (Alexion Astrazeneca Rare Disease), AstraZeneca, speaks with Savio Rodrigues, Head of New Business Acquisition at Trianz and CDO Magazine Editorial Board Member, about transforming healthcare with AI, on AI diagnostics potential to improve the diagnostic journey, and health equity for rare disease patients.